Modulation of β-cell function: A translational journey from the bench to the bedside

Diabetes, Obesity and Metabolism

Volumn 14, Issue SUPPL.3, 2012, Pages 152-160

  Goldfine, A B ^a,b,c   Kulkarni, R N ^a,b,c  

^a JOSLIN DIABETES CENTER   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Human; Insulin resistance; Insulin secretion; Type 2 diabetes; cell

Indexed keywords

C PEPTIDE; FATTY ACID; GLUCOSE; GLYCOGEN SYNTHASE KINASE 3; INSULIN; INSULIN ASPART; INSULIN RECEPTOR; INSULIN RECEPTOR SUBSTRATE; INSULIN RECEPTOR SUBSTRATE 1; INSULIN RECEPTOR SUBSTRATE 2; INSULIN RECEPTOR SUBSTRATE 3; INSULIN RECEPTOR SUBSTRATE 4; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN KINASE B; SOMATOMEDIN C; UNCLASSIFIED DRUG;

AGING; AUTOCRINE EFFECT; CELL GROWTH; DIABETOGENESIS; GLUCOSE HOMEOSTASIS; GLUCOSE INTOLERANCE; HUMAN; INSULIN RELEASE; INSULIN RESISTANCE; INSULIN SENSITIVITY; INTRACELLULAR SIGNALING; METABOLIC REGULATION; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PANCREAS ISLET BETA CELL; PANCREAS ISLET CELL FUNCTION; PARACRINE SIGNALING; PATHOGENESIS; PATHOPHYSIOLOGY; PROTEIN PHOSPHORYLATION; REVIEW;

EID: 84865586055     PISSN: 14628902     EISSN: 14631326     Source Type: Journal    
DOI: 10.1111/j.1463-1326.2012.01647.x     Document Type: Review

References (85)

1. LeRoith D, Gavrilova O. Mouse models created to study the pathophysiology of Type 2 diabetes. Int J Biochem Cell Biol 2006; 38: 904-912.
2. Kulkarni RN, Bruning JC, Winnay JN, Postic C, Magnuson MA, Kahn CR. Tissue-specific knockout of the insulin receptor in pancreatic beta cells creates an insulin secretory defect similar to that in type 2 diabetes. Cell 1999; 96: 329-339.
3. Stagner J, Samols E, Polonsky K, Pugh W. Lack of direct inhibition of insulin secretion by exogenous insulin in the canine pancreas. J Clin Invest 1986; 78: 1193-1198.
4. Van Schravendijk CF, Heylen L, Van den Brande JL, Pipeleers DG. Direct effect of insulin and insulin-like growth factor-I on the secretory activity of rat pancreatic beta cells. Diabetologia 1990; 33: 649-653.
5. Elahi D, Nagulesparan M, Hershcopf RJ et al. Feedback inhibition of insulin secretion by insulin: relation to the hyperinsulinemia of obesity. N Engl J Med 1982; 306: 1196-1202.
6. Argoud GM, Schade DS, Eaton RP. Insulin suppresses its own secretion in vivo. Diabetes 1987; 36: 959-962.
7. Draznin B, Goodman M, Leitner JW, Sussman KE. Feedback inhibition of insulin on insulin secretion in isolated pancreatic islets. Endocrinology 1986; 118: 1054-1058.
8. Iversen J, Miles DW. Evidence for a feedback inhibition of insulin on insulin secretion in the isolated, perfused canine pancreas. Diabetes 1971; 20: 1-9.
9. Gazzano H, Halban P, Prentki M et al. Identification of functional insulin receptors on membranes from an insulin-producing cell line (RINm5F). Biochem J 1985; 226: 867-872.
10. Kulkarni RN, Winnay JN, Daniels M et al. Altered function of insulin receptor substrate-1-deficient mouse islets and cultured beta-cell lines. J Clin Invest 1999; 104: R69-R75.
11. Luciani DS, Johnson JD. Acute effects of insulin on beta-cells from transplantable human islets. Mol Cell Endocrinol 2005; 241: 88-98.
12. Muller D, Huang GC, Amiel S, Jones PM, Persaud SJ. Identification of insulin signaling elements in human beta-cells: autocrine regulation of insulin gene expression. Diabetes 2006; 55: 2835-2842.
13. Bernal-Mizrachi E, Wen W, Stahlhut S, Welling CM, Permutt MA. Islet beta cell expression of constitutively active Akt1/PKB alpha induces striking hypertrophy, hyperplasia, and hyperinsulinemia. J Clin Invest 2001; 108: 1631-1638.
14. Gunton JE, Kulkarni RN, Yim S et al. Loss of ARNT/HIF1beta mediates altered gene expression and pancreatic-islet dysfunction in human type 2 diabetes. Cell 2005; 122: 337-349.
15. Folli F, Okada T, Perego C et al. Altered insulin receptor signalling and beta-cell cycle dynamics in type 2 diabetes mellitus. PLoS One 2011; 6: e28050.
16. Okada T, Liew CW, Hu J et al. Insulin receptors in beta-cells are critical for islet compensatory growth response to insulin resistance. Proc Natl Acad Sci U S A 2007; 104: 8977-8982.
17. Accili D, Drago J, Lee EJ et al. Early neonatal death in mice homozygous for a null allele of the insulin receptor gene. Nat Genet 1996; 12: 106-109.
18. Kido Y, Nakae J, Hribal ML, Xuan S, Efstratiadis A, Accili D. Effects of mutations in the insulin-like growth factor signaling system on embryonic pancreas development and beta-cell compensation to insulin resistance. J Biol Chem 2002; 277: 36740-36747.
19. Kulkarni RN, Holzenberger M, Shih DQ et al. Beta-cell-specific deletion of the IGF1 receptor leads to hyperinsulinemia and glucose intolerance but does not alter beta-cell mass. Nat Genet 2002; 31: 111-115.
20. Xuan S, Kitamura T, Nakae J et al. Defective insulin secretion in pancreatic beta cells lacking type 1 IGF receptor. J Clin Invest 2002; 110: 1011-1019.
21. Otani K, Kulkarni RN, Baldwin AC et al. Reduced beta-cell mass and altered glucose sensing impair insulin-secretory function in betaIRKO mice. Am J Physiol Endocrinol Metab 2004; 286: 41-49.
22. Ueki K, Okada T, Hu J et al. Total insulin and IGF-I resistance in pancreatic beta cells causes overt diabetes. Nat Genet 2006; 38: 583-588.
23. 2+ stores in insulin-stimulated insulin secretion in beta-cells. J Biol Chem 2000; 275: 22331-22338.
24. Henquin JC. Triggering and amplifying pathways of regulation of insulin secretion by glucose. Diabetes 2000; 49: 1751-1760.
25. 2+-ATPase (SERCA)-2b and -3. Diabetes 2004; 53: 1517-1525.
26. Leibiger B, Leibiger IB, Moede T et al. Selective insulin signaling through A and B insulin receptors regulates transcription of insulin and glucokinase genes in pancreatic beta cells. Mol Cell 2001; 7: 559-570.
27. Da Silva Xavier G, Qian Q, Cullen PJ, Rutter GA. Distinct roles for insulin and insulin-like growth factor-1 receptors in pancreatic beta-cell glucose sensing revealed by RNA silencing. Biochem J 2004; 377: 149-158.
28. Westerlund J, Wolf BA, Bergsten P. Glucose-dependent promotion of insulin release from mouse pancreatic islets by the insulin-mimetic compound L-783, 281. Diabetes 2002; 51: 50-52.
29. Lee EK, Kim W, Tominaga K et al. RNA-binding protein HuD controls insulin translation. Mol Cell 2012; 6: 826-835.
30. Jacques-Silva MC, Correa-Medina M, Cabrera O et al. ATP-gated P2X3 receptors constitute a positive autocrine signal for insulin release in the human pancreatic beta cell. Proc Natl Acad Sci U S A 2010; 107: 6465-6470.
31. Assmann A, Ueki K, Winnay JN, Kadowaki T, Kulkarni RN. Glucose effects on beta-cell growth and survival require activation of insulin receptors and insulin receptor substrate 2. Mol Cell Biol 2009; 29: 3219-3228.
32. Federici M, Hribal M, Perego L et al. High glucose causes apoptosis in cultured human pancreatic islets of Langerhans: a potential role for regulation of specific Bcl family genes toward an apoptotic cell death program. Diabetes 2001; 50: 1290-1301.
33. Kubota N, Tobe K, Terauchi Y et al. Disruption of insulin receptor substrate 2 causes type 2 diabetes because of liver insulin resistance and lack of compensatory beta-cell hyperplasia. Diabetes 2000; 49: 1880-1889.
34. Porzio O, Federici M, Hribal ML et al. The Gly972-->Arg amino acid polymorphism in IRS-1 impairs insulin secretion in pancreatic beta cells. J Clin Invest 1999; 104: 357-364.
35. Georgia S, Hinault C, Kawamori D et al. Cyclin D2 is essential for the compensatory beta-cell hyperplastic response to insulin resistance in rodents. Diabetes 2010; 59: 987-996.
36. Leibiger B, Wahlander K, Berggren PO, Leibiger IB. Glucose-stimulated insulin biosynthesis depends on insulin-stimulated insulin gene transcription. J Biol Chem 2000; 275: 30153-30156.
37. Hennige AM, Ozcan U, Okada T et al. Alterations in growth and apoptosis of insulin receptor substrate-1-deficient beta-cells. Am J Physiol Endocrinol Metab 2005; 289: 337-346.
38. Araki E, Lipes MA, Patti ME et al. Alternative pathway of insulin signalling in mice with targeted disruption of the IRS-1 gene. Nature 1994; 372: 186-190.
39. Withers DJ, Gutierrez JS, Towery H et al. Disruption of IRS-2 causes type 2 diabetes in mice. Nature 1998; 391: 900-904.
40. Kubota N, Terauchi Y, Tobe K et al. Insulin receptor substrate 2 plays a crucial role in beta cells and the hypothalamus. J Clin Invest 2004; 114: 917-927.
41. Cantley J, Choudhury AI, Asare-Anane H et al. Pancreatic deletion of insulin receptor substrate 2 reduces beta and alpha cell mass and impairs glucose homeostasis in mice. Diabetologia 2007; 50: 1248-1256.
42. Cho H, Mu J, Kim JK et al. Insulin resistance and a diabetes mellitus-like syndrome in mice lacking the protein kinase Akt2 (PKB beta). Science 2001; 292: 1728-1731.
43. Bernal-Mizrachi E, Fatrai S, Johnson JD et al. Defective insulin secretion and increased susceptibility to experimental diabetes are induced by reduced Akt activity in pancreatic islet beta cells. J Clin Invest 2004; 114: 928-936.
44. Tuttle RL, Gill NS, Pugh W et al. Regulation of pancreatic beta-cell growth and survival by the serine/threonine protein kinase Akt1/PKBalpha. Nat Med 2001; 7: 1133-1137.
45. Watanabe H, Saito H, Ueda J, Evers BM. Regulation of pancreatic duct cell differentiation by phosphatidylinositol-3 kinase. Biochem Biophys Res Commun 2008; 370: 33-37.
46. Liang J, Slingerland JM. Multiple roles of the PI3K/PKB (Akt) pathway in cell cycle progression. Cell Cycle 2003; 2: 339-345.
47. Elghazi L, Rachdi L, Weiss AJ, Cras-Meneur C, Bernal-Mizrachi E. Regulation of beta-cell mass and function by the Akt/protein kinase B signalling pathway. Diabetes Obes Metab 2007; 9: 147-157.
48. Manning BD, Cantley LC. AKT/PKB signaling: navigating downstream. Cell 2007; 129: 1261-1274.
49. Fatrai S, Elghazi L, Balcazar N et al. Akt induces beta-cell proliferation by regulating cyclin D1, cyclin D2, and p21 levels and cyclin-dependent kinase-4 activity. Diabetes 2006; 55: 318-325.
50. Diehl JA, Cheng M, Roussel MF, Sherr CJ. Glycogen synthase kinase-3beta regulates cyclin D1 proteolysis and subcellular localization. Genes Dev 1998; 12: 3499-3511.
51. Huang W, Chang HY, Fei T, Wu H, Chen YG. GSK3 beta mediates suppression of cyclin D2 expression by tumor suppressor PTEN. Oncogene 2007; 26: 2471-2482.
52. Heron-Milhavet L, Franckhauser C, Rana V et al. Only Akt1 is required for proliferation, while Akt2 promotes cell cycle exit through p21 binding. Mol Cell Biol 2006; 26: 8267-8280.
53. Kitamura T, Ido Kitamura Y. Role of FoxO proteins in pancreatic beta cells. Endocr J 2007; 54: 507-515.
54. Ramaswamy S, Nakamura N, Sansal I, Bergeron L, Sellers WR. A novel mechanism of gene regulation and tumor suppression by the transcription factor FKHR. Cancer Cell 2002; 2: 81-91.
55. Medema RH, Kops GJ, Bos JL, Burgering BM. AFX-like Forkhead transcription factors mediate cell-cycle regulation by Ras and PKB through p27kip1. Nature 2000; 404: 782-787.
56. Kitamura T, Nakae J, Kitamura Y et al. The forkhead transcription factor Foxo1 links insulin signaling to Pdx1 regulation of pancreatic beta cell growth. J Clin Invest 2002; 110: 1839-1847.
57. Feng J, Tamaskovic R, Yang Z et al. Stabilization of Mdm2 via decreased ubiquitination is mediated by protein kinase B/Akt-dependent phosphorylation. J Biol Chem 2004; 279: 35510-35517.
58. Kim W, Doyle ME, Liu Z et al. Cannabinoids inhibit insulin receptor signaling in pancreatic beta-cells. Diabetes 2011; 60: 1198-1209.
59. Kim W, Lao Q, Shin YK et al. Cannabinoids induce pancreatic beta-cell death by directly inhibiting insulin receptor activation. Sci Signal 2012; 216: ra23.
60. Aspinwall CA, Lakey JR, Kennedy RT. Insulin-stimulated insulin secretion in single pancreatic beta cells. J Biol Chem 1999; 274: 6360-6365.
61. Almind K, Bjorbaek C, Vestergaard H, Hansen T, Echwald S, Pedersen O. Aminoacid polymorphisms of insulin receptor substrate-1 in non-insulin-dependent diabetes mellitus. Lancet 1993; 342: 828-832.
62. Marchetti P, Lupi R, Federici M et al. Insulin secretory function is impaired in isolated human islets carrying the Gly(972)-->Arg IRS-1 polymorphism. Diabetes 2002; 51: 1419-1424.
63. Best CH, Haist RE. The effect of insulin administration on the insulin content of the pancreas. J Physiol 1941; 100: 142-146.
64. Marangou AG, Weber KM, Boston RC et al. Metabolic consequences of prolonged hyperinsulinemia in humans. Evidence for induction of insulin insensitivity. Diabetes 1986; 35: 1383-1389.
65. Kraegen EW, Lazarus L, Campbell LV. Failure of insulin infusion during euglycemia to influence endogenous basal insulin secretion. Metabolism 1983; 32: 622-627.
66. Del Prato S, Leonetti F, Simonson DC, Sheehan P, Matsuda M, DeFronzo RA. Effect of sustained physiologic hyperinsulinaemia and hyperglycaemia on insulin secretion and insulin sensitivity in man. Diabetologia 1994; 37: 1025-1035.
67. Ward GM, Walters JM, Aitken PM, Best JD, Alford FP. Effects of prolonged pulsatile hyperinsulinemia in humans. Enhancement of insulin sensitivity. Diabetes 1990; 39: 501-507.
68. Polonsky KS, Rubenstein AH. C-peptide as a measure of the secretion and hepatic extraction of insulin. Pitfalls and limitations. Diabetes 1984; 33: 486-494.
69. Bouche C, Lopez X, Fleischman A et al. Insulin enhances glucose-stimulated insulin secretion in healthy humans. Proc Natl Acad Sci U S A 2010; 107: 4770-4775.
70. Neerman-Arbez M, Halban PA. Novel, non-crinophagic, degradation of connecting peptide in transformed pancreatic beta cells. J Biol Chem 1993; 268: 16248-16252.
71. Mari A, Tura A, Natali A et al. Influence of hyperinsulinemia and insulin resistance on in vivo beta-cell function: their role in human beta-cell dysfunction. Diabetes 2011; 60: 3141-3147.
72. Lopez X, Cypess A, Manning R, O'Shea S, Kulkarni RN, Goldfine AB. Exogenous insulin enhances glucose-stimulated insulin response in healthy humans independent of changes in free fatty acids. J Clin Endocrinol Metab 2011; 96: 3811-3821.
73. Halperin F, Lopez X, Manning R, Kahn CR, Kulkarni RN, Goldfine AB. Insulin augmentation of glucose-stimulated insulin secretion is impaired in insulin-resistant humans. Diabetes 2012; 61: 301-309.
74. Anderwald C, Tura A, Grassi A et al. Insulin infusion during normoglycemia modulates insulin secretion according to whole-body insulin sensitivity. Diabetes Care 2011; 34: 437-441.
75. Carpentier A, Mittelman SD, Lamarche B, Bergman RN, Giacca A, Lewis GF. Acute enhancement of insulin secretion by FFA in humans is lost with prolonged FFA elevation. Am J Physiol Endocrinol Metab 1999; 276: 1055-1066.
76. Dobbins RL, Chester MW, Daniels MB, McGarry JD, Stein DT. Circulating fatty acids are essential for efficient glucose-stimulated insulin secretion after prolonged fasting in humans. Diabetes 1998; 47: 1613-1618.
77. Nolan CJ, Madiraju MS, Delghingaro-Augusto V, Peyot ML, Prentki M. Fatty acid signaling in the beta-cell and insulin secretion. Diabetes 2006; 55: 16-23.
78. Kahn SE. The relative contributions of insulin resistance and beta-cell dysfunction to the pathophysiology of Type 2 diabetes. Diabetologia 2003; 46: 3-19.
79. Butler AE, Janson J, Bonner-Weir S, Ritzel R, Rizza RA, Butler PC. Beta-cell deficit and increased beta-cell apoptosis in humans with type 2 diabetes. Diabetes 2003; 52: 102-110.
80. Cnop M, Vidal J, Hull RL et al. Progressive loss of beta-cell function leads to worsening glucose tolerance in first-degree relatives of subjects with type 2 diabetes. Diabetes Care 2007; 30: 677-682.
81. Ehrmann DA, Breda E, Cavaghan MK et al. Insulin secretory responses to rising and falling glucose concentrations are delayed in subjects with impaired glucose tolerance. Diabetologia 2002; 45: 509-517.
82. Ferrannini E, Gastaldelli A, Miyazaki Y, Matsuda M, Mari A, DeFronzo RA. Beta-cell function in subjects spanning the range from normal glucose tolerance to overt diabetes: a new analysis. J Clin Endocrinol Metab 2005; 90: 493-500.
83. Grill V, Adamson U, Cerasi E. Immediate and time-dependent effects of glucose on insulin release from rat pancreatic tissue. Evidence for different mechanisms of action. J Clin Invest 1978; 61: 1034-1043.
84. Ward WK, Halter JB, Beard JC, Porte D, Jr. Adaptation of B and A cell function during prolonged glucose infusion in human subjects. Am J Physiol 1984; 246: 405-411.
85. Nesher R, Cerasi E. Modeling phasic insulin release: immediate and time-dependent effects of glucose. Diabetes 2002; 51(Suppl. 1): 53-59.